Terrance P. Coyne, EVP & CFO at Royalty Pharma plc (RPRX), sold 11,002 shares at $58.59 ($646K) on 2026-08-13, disclosed to the SEC on 2026-08-17.
Scheduled sale ($646k) by EVP & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.59 | 9,230 | $541K | 83.8% |
| 2 | $59.14 | 1,772 | $105K | 16.2% |
| Total | $58.68 avg | 11,002 | $646K | 100% |
| Filing → |
| RPRX | SELL | 2026-04-02 | $1.7M | — | Filing → |
| RPRX | SELL | 2026-03-25 | $3.2M | — | Filing → |
| RPRX | SELL | 2026-03-04 | $3.3M | — | Filing → |